<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">86260</article-id><article-id pub-id-type="doi">10.7554/eLife.86260</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>Endothelial dysfunction in acute myocardial infarction: cell-autonomous metabolic reprogramming and oxidative stress</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-311421"><name><surname>Zodda</surname><given-names>Erika</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-311422"><name><surname>Tura-Ceide</surname><given-names>Olga</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-311423"><name><surname>Mills</surname><given-names>Nicholas L</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-311424"><name><surname>Tarragó-Celada</surname><given-names>Josep</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-311425"><name><surname>Carini</surname><given-names>Marina</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" corresp="yes" id="author-37783"><name><surname>Thomson</surname><given-names>Timothy M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4670-9440</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" corresp="yes" id="author-212137"><name><surname>Cascante</surname><given-names>Marta</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2062-4633</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Biochemistry and Molecular Biology</institution>, <institution>University of Barcelona</institution>, <addr-line><named-content content-type="city">Barcelona</named-content></addr-line>, <country>Spain</country></aff><aff id="aff2"><institution content-type="dept">Department of Pulmonary Medicine</institution>, <institution>Dr Josep Trueta University Hospital de Girona</institution>, <addr-line><named-content content-type="city">Girona</named-content></addr-line>, <country>Spain</country></aff><aff id="aff3"><institution content-type="dept">BHF Centre for Cardiovascular Science</institution>, <institution>University of Edinburgh</institution>, <addr-line><named-content content-type="city">Edinburgh</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff4"><institution content-type="dept">Department of Pharmaceutical Sciences</institution>, <institution>Università degli Studi di Milano</institution>, <addr-line><named-content content-type="city">Milan</named-content></addr-line>, <country>Italy</country></aff><aff id="aff5"><institution content-type="dept">Institute for Molecular Biology of Barcelona</institution>, <institution>Spanish National Research Council</institution>, <addr-line><named-content content-type="city">Barcelona</named-content></addr-line>, <country>Spain</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-136599"><name><surname>Janus</surname><given-names>Edward D</given-names></name><role>Reviewing editor</role><aff><institution>University of Melbourne</institution>, <country>Australia</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>titbmc@ibmb.csic.es</email> (TT);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>martacascante@ub.edu</email> (MC);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>28</day><month>11</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e86260</elocation-id><history><date date-type="received"><day>18</day><month>01</month><year>2023</year></date><date date-type="accepted"><day>01</day><month>08</month><year>2023</year></date></history><permissions><copyright-statement>© 2023, Zodda et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Zodda et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-86260-v1.pdf"/><abstract><p><bold>Background:</bold> Compelling evidence has accumulated on the role of oxidative stress on the endothelial cell (EC) dysfunction underlying acute coronary syndrome. However, unveiling the underlying metabolic determinants has been hampered by the scarcity of appropriate cell models to address cell-autonomous mechanisms of ED dysfunction. </p><p><bold>Methods:</bold> We have generated endothelial cells derived from thrombectomy specimens from patients affected with acute myocardial infarction (AMI) and conducted phenotypical and metabolic characterization, focused on central carbon metabolism. </p><p><bold>Results:</bold> AMI-derived endothelial cells (AMIECs), but not control healthy coronary endothelial cells, display impaired growth, migration and tubulogenesis. Metabolically, AMIECs displayed augmented reactive oxygen species (ROS) and glutathione intracellular content, along with a diminished glucose consumption coupled to high lactate production. Consistent with diminished glycolysis in AMIECs, the protein levels of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase type 3, PFKFB3, were downregulated. In contrast, PFKFB4 levels were upregulated, suggesting a shunting of glycolysis towards the pentose phosphate pathway (PPP), supported by upregulation in AMIECs of G6PD, the key enzyme in the oxidative branch of the PPP. Further, the glutaminolytic enzyme GLS was upregulated in AMIECs, providing a mechanistic explanation for the observed increase in glutathione content. Finally, AMIECs displayed a significantly higher mitochondrial membrane potential than control ECs, which, together with high ROS levels, suggest a highly coupled mitochondrial activity in patient ECs. </p><p><bold>Conclusions:</bold> We suggest high mitochondrial proton coupling underlies the abnormally high production of ROS, balanced by PPP- and glutaminolysis-driven synthesis of glutathione, as a primary, cell-autonomous abnormality driving EC dysfunction in AMI. </p><p><bold>Funding:</bold> European Commission Horizon 2020; CIBER- Carlos III National Institute of Health, Spain; Ministerio de Economia y Competitividad (MINECO) and Ministerio de Ciencia e Innovación, Spain; Generalitat de Catalunya-AGAUR, Catalonia; Plataforma Temática Interdisciplinar Salud Global (PTI-SG), Spain; British Heart Foundation, UK.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>CIBER Carlos III National Institute of Health</institution></institution-wrap></funding-source><award-id>CIBEREHD-CB17/04/00023</award-id><principal-award-recipient><name><surname>Carini</surname><given-names>Marina</given-names></name><name><surname>Thomson</surname><given-names>Timothy M</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>CIBER Carlos III National Institute of Health</institution></institution-wrap></funding-source><award-id>CIBERES-CP17/00114</award-id><principal-award-recipient><name><surname>Tura-Ceide</surname><given-names>Olga</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>Spanish Ministerio de Economia y Competitividad</institution></institution-wrap></funding-source><award-id>PID2019-107139RB-C21</award-id><principal-award-recipient><name><surname>Thomson</surname><given-names>Timothy M</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>Spanish Ministerio de Economia y Competitividad</institution></institution-wrap></funding-source><award-id>PID2020-115051RB-I00</award-id><principal-award-recipient><name><surname>Carini</surname><given-names>Marina</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution>Generalitat de Catalunya-AGAUR</institution></institution-wrap></funding-source><award-id>2021 SGR00350</award-id><principal-award-recipient><name><surname>Carini</surname><given-names>Marina</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution>Generalitat de Catalunya-AGAUR</institution></institution-wrap></funding-source><award-id>2021 SGR1490</award-id><principal-award-recipient><name><surname>Thomson</surname><given-names>Timothy M</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution>Plataforma Temática Interdisciplinar - Salud Global</institution></institution-wrap></funding-source><award-id>SGL2103019</award-id><principal-award-recipient><name><surname>Thomson</surname><given-names>Timothy M</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Erika Zodda, The European Commission Horizon 2020 research and innovation program under the MOGLYNET H2020-MSCAITNEJD grant (agreement No 675527): salary and research fundsGeneralitat de Catalunya-AGAUR: salary and research fundsPlataforma Temática Interdisciplinar - Salud Global: salary, travel expenses and research fundsMinisterio de Ciencia e Innovación, Spain: salary and research funds.</p></fn><fn fn-type="conflict" id="conf3"><p>Nicholas L Mills, European Commission Horizon 2020 research and innovation program under the MOGLYNET H2020-MSCA-ITN-EJD grant: research funds.</p></fn><fn fn-type="conflict" id="conf4"><p>Marina Carini, European Commission Horizon 2020 research and innovation program under the MOGLYNET H2020-MSCA-ITN-EJD grant: research funds and travel expenses.</p></fn><fn fn-type="conflict" id="conf5"><p>Timothy M Thomson, CIBER- Carlos III National Institute of Health, Spain: research fundsMinisterio de Ciencia e Innovación, Spain: research fundsGeneralitat de Catalunya-AGAUR: research fundsPlataforma Temática Interdisciplinar - Salud Global: research funds.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Acute myocardial infection patient-derived endothelial cells (AMIECs) were isolated from coronary atherothrombotic specimens in patients undergoing percutaneous coronary intervention with thrombectomy for the treatment of acute ST-segment elevation myocardial infarction (STEMI) at the Royal Infirmary of Edinburgh, Scotland, UK. The study protocol was approved by the Institutional Research Ethics Committee, and all subjects provided written informed consent.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript.</p></sec><supplementary-material><ext-link xlink:href="elife-86260-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>